相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive Biomarkers of Sensitivity to the Aurora and Angiogenic Kinase Inhibitor ENMD-2076 in Preclinical Breast Cancer Models
Jennifer R. Diamond et al.
CLINICAL CANCER RESEARCH (2013)
p53-Mediated Senescence Impairs the Apoptotic Response to Chemotherapy and Clinical Outcome in Breast Cancer
James G. Jackson et al.
CANCER CELL (2012)
Transcriptional analysis of the Aurora inhibitor Danusertib leading to biomarker identification in TP53 wild type cells
Roberta Bosotti et al.
GENE (2012)
Sensitivity of BRCA2 mutated human cell lines to Aurora kinase inhibition
Linda Vidarsdottir et al.
INVESTIGATIONAL NEW DRUGS (2012)
Treatment of human pre-B acute lymphoblastic leukemia with the Aurora kinase inhibitor PHA-739358 (Danusertib)
Fei Fei et al.
MOLECULAR CANCER (2012)
Inhibiting Aurora Kinases Reduces Tumor Growth and Suppresses Tumor Recurrence after Chemotherapy in Patient-Derived Triple-Negative Breast Cancer Xenografts
Angela Romanelli et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Dacomitinib (PF-00299804), an Irreversible Pan-HER Inhibitor, Inhibits Proliferation of HER2-Amplified Breast Cancer Cell Lines Resistant to Trastuzumab and Lapatinib
Ondrej Kalous et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Subtype and pathway specific responses to anticancer compounds in breast cancer
Laura M. Heiser et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
BPR1K653, a Novel Aurora Kinase Inhibitor, Exhibits Potent Anti-Proliferative Activity in MDR1 (P-gp170)-Mediated Multidrug-Resistant Cancer Cells
Chun Hei Antonio Cheung et al.
PLOS ONE (2011)
Targets and effectors of the cellular response to aurora kinase inhibitor MK-0457 (VX-680) in imatinib sensitive and resistant chronic myelogenous leukemia
Nicholas J. Donato et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Aurora kinase inhibitor ZM447439 induces apoptosis via mitochondrial pathways
Minglun Li et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Aurora kinases A and B are up-regulated by Myc and are essential for maintenance of the malignant state
Juergen den Hollander et al.
BLOOD (2010)
Anovel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
Guellue Goerguen et al.
BLOOD (2010)
Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines
Marc Payton et al.
CANCER RESEARCH (2010)
Combination of nutlin-3 and VX-680 selectively targets p53 mutant cells with reversible effects on cells expressing wild-type p53
C. F. Cheok et al.
CELL DEATH AND DIFFERENTIATION (2010)
The FLT3 Internal Tandem Duplication Mutation Is a Secondary Target of the Aurora B Kinase Inhibitor AZD1152-HQPA in Acute Myelogenous Leukemia Cells
Martin Grundy et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Shared and separate functions of polo-like kinases and aurora kinases in cancer
Susanne M. A. Lens et al.
NATURE REVIEWS CANCER (2010)
Aurora kinase inhibitors in preclinical and clinical testing
Chun Hei Antonio Cheung et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Aurora B Kinase Regulates the Postmitotic Endoreduplication Checkpoint via Phosphorylation of the Retinoblastoma Protein at Serine 780
Jayasree S. Nair et al.
MOLECULAR BIOLOGY OF THE CELL (2009)
Determinants for the efficiency of anticancer drugs targeting either Aurora-A or Aurora-B kinases in human colon carcinoma cells
Phillip Kaestner et al.
MOLECULAR CANCER THERAPEUTICS (2009)
PD 0332991, a selective cyclin D kinase 4/6 inhibitor, preferentially inhibits proliferation of luminal estrogen receptor-positive human breast cancer cell lines in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH (2009)
Aurora Kinase A Inhibition Leads to p73-Dependent Apoptosis in p53-Deficient Cancer Cells
Altaf A. Dar et al.
CANCER RESEARCH (2008)
TP53 status and response to chemotherapy in breast cancer
Philippe Bertheau et al.
PATHOBIOLOGY (2008)
Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152
Y. Tao et al.
ONCOGENE (2008)
Mechanism of action of the Aurora kinase inhibitor CCT129202 and in vivo quantification of biological activity
Florence Chan et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/triple-negative'' breast cancer cell lines growing in vitro
Richard S. Finn et al.
BREAST CANCER RESEARCH AND TREATMENT (2007)
A novel treatment strategy targeting Aurora kinases in acute myelogenous leukemia
Takayuki Ikezoe et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The Aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function
Farid Gizatullin et al.
CANCER RESEARCH (2006)
Apoptosis regulation in tetraploid cancer cells
Maria Castedo et al.
EMBO JOURNAL (2006)
Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas
P Kringen et al.
BIOTECHNIQUES (2005)
The in vitro and in vivo effects of JNJ-7706621:: A dual inhibitor of cyclin-dependent kinases and aurora kinases
S Emanuel et al.
CANCER RESEARCH (2005)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Aurora B couples chromosome alignment with anaphase by targeting BubR1, Mad2, and Cenp-E to kinetochores
C Ditchfield et al.
JOURNAL OF CELL BIOLOGY (2003)
The small molecule Hesperadin reveals a role for Aurora B in correcting kinetochore-microtubule attachment and in maintaining the spindle assembly checkpoint
S Hauf et al.
JOURNAL OF CELL BIOLOGY (2003)
G1 tetraploidy checkpoint and the suppression of tumorigenesis
RL Margolis et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
P21/WAF1/Cip1 expression in invasive ductal breast carcinoma: relationship to p53, proliferation rate, and survival at 5 years
W Domagala et al.
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2001)
Mitotic kinases as regulators of cell division and its checkpoints
EA Nigg
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
分享论文
